HHS Pandemic Response Plan Could Be Hindered By SEC Regulations
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS' efforts to increase manufacturing capacity to prepare for an influenza pandemic could be affected if manufacturers are unable to record stockpile revenue under Securities & Exchange Commission regulations
You may also be interested in...
Flu Pandemic Plan: Financial Incentives To Increase Manufacturing Capacity
HHS plans to increase its demand for influenza vaccine to strengthen the vaccine delivery system and expand manufacturing capacity, a draft document states. Use of adjuvants could expand the vaccine supply, HHS suggests.
Flu Pandemic Plan: Financial Incentives To Increase Manufacturing Capacity
HHS plans to increase its demand for influenza vaccine to strengthen the vaccine delivery system and expand manufacturing capacity, a draft document states. Use of adjuvants could expand the vaccine supply, HHS suggests.
Vaccine Stockpile For HHS May Be Delayed By SEC Regs
Accounting regulations hinder booking payments from HHS for products which firms stockpile themselves, Aventis VP Hosbach says. Industry may seek an SEC exemption or a change in the contract language from CDC.